A case of multiple brain abscesses due to Bacillus cereus during induction therapy for acute myeloid leukemia Jun NukuiMasatsugu TanakaHideaki Nakajima Images in Hematology 07 October 2021 Pages: 637 - 638
Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review Hirotaka MoriMasahiko FukatsuTakayuki Ikezoe Review Article 30 August 2021 Pages: 639 - 652
Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial Kenshi SuzukiChang-Ki MinShinsuke Iida Original Article 19 August 2021 Pages: 653 - 663
Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation Chikako OhwadaShingo YamazakiEmiko Sakaida Original Article 14 September 2021 Pages: 664 - 673
Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors Kazuki YoshimuraShun-ichi KimuraYoshinobu Kanda Original Article 11 August 2021 Pages: 674 - 681
Assessment of cellular response to mitogens in long-term allogeneic hematopoietic stem cell transplantation survivors Takahiko SatoMiyo GotoKoichi Miyamura Original Article 22 August 2021 Pages: 682 - 690
Granulocyte collection by polymorphonuclear cell-targeting apheresis with medium-molecular-weight hydroxyethyl starch Tomoko HenzanTakuji YamauchiYuya Kunisaki Original Article 28 August 2021 Pages: 691 - 700
Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation Taiga KuroiNobuharu FujiiYoshinobu Maeda Original Article 07 September 2021 Pages: 701 - 708
Practical management of patients with hematological diseases during the COVID-19 pandemic in Japan Masao HagiharaShin OharaMorihiro Inoue Original Article 20 October 2021 Pages: 709 - 718
Clinical characteristics and risk factors associated with nosocomial COVID-19 infection in patients with hematological disorders in Japan Shin OharaTakayuki FujiiMasao Hagaihara Original Article 21 June 2021 Pages: 719 - 724
Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA Dmitry EvseevIrina KalininaMichael Maschan Original Article 12 August 2021 Pages: 725 - 734
Refractory T-cell/histiocyte-rich large B-cell lymphoma in a patient with ataxia–telangiectasia caused by novel compound heterozygous variants in ATM Daichi SatoKunihiko MoriyaShigeo Kure Case Report 23 August 2021 Pages: 735 - 741
Correction to: Somatic SETBP1 mutations in myeloid neoplasms Hideki Makishima Correction 23 October 2021 Pages: 742 - 742
